Literature DB >> 12208705

Serial paracenteses in the management of acute elevations of intraocular pressure.

Matthew C Carnahan1, Lawrence W Platt.   

Abstract

OBJECTIVE: To study the effectiveness of serial paracenteses in eyes with symptomatic elevated intraocular pressure (IOP).
DESIGN: Retrospective, noncomparative, interventional case series. PARTICIPANTS: Five eyes of four patients with acute elevations in IOP.
METHODS: A 5-year review of records was performed in one practice (LP) to identify patients who underwent more than one paracentesis for control of symptomatic increases in IOP when greater than 30 mmHg. Five eyes of four patients were identified, and charts were analyzed for cause and duration of elevated pressure, control of symptoms associated with elevated pressure, number of paracenteses, and visual outcome. All patients received topical anesthetic (proparacaine 0.5%) before paracentesis, and topical ciprofloxacin, 0.35%, or tobramycin, 0.3%, before and after paracentesis, which was performed at the temporal limbus with a 0.75-mm sterile surgical blade.
RESULTS: Paracentesis provided almost immediate symptomatic relief in all cases. The procedure could be repeated easily whenever symptoms recurred. The average number of paracenteses performed was three. No complications of paracentesis were noted. Visual outcomes were variable and dependent on the etiology of elevated IOP. Two eyes with neovascular glaucoma had poor visual outcomes. None of the other three eyes lost vision because of increased IOP.
CONCLUSIONS: Acute symptomatic elevations of IOP in patients with a deep anterior chamber can be effectively treated with paracentesis. In selected cases, serial paracenteses may obviate the need for filtration surgery. If filtration surgery is required, serial paracenteses may allow it to be scheduled electively rather than emergently.

Entities:  

Mesh:

Year:  2002        PMID: 12208705     DOI: 10.1016/s0161-6420(02)01126-0

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  8 in total

1.  The safety of anterior chamber paracentesis in patients with uveitis.

Authors:  C M G Cheung; O M Durrani; P I Murray
Journal:  Br J Ophthalmol       Date:  2004-04       Impact factor: 4.638

2.  Anterior chamber paracentesis in patients with acute elevation of intraocular pressure.

Authors:  Stéphane Arnavielle; Catherine Creuzot-Garcher; Alain M Bron
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-11-17       Impact factor: 3.117

3.  Anterior chamber paracentesis and pH values in patients with acute primary angle closure.

Authors:  Da-Wen Lu; Ming-Cheng Tai; Yun-Hsiang Chang; Chang-Min Liang; Ching-Long Chen; Ke-Hung Chien; Jiann-Torng Chen; Yi-Hao Chen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-11-11       Impact factor: 3.117

4.  Sustained elevation of extracellular ATP in aqueous humor from humans with primary chronic angle-closure glaucoma.

Authors:  Ang Li; Xiulan Zhang; Danying Zheng; Jian Ge; Alan M Laties; Claire H Mitchell
Journal:  Exp Eye Res       Date:  2011-07-02       Impact factor: 3.467

5.  The Magnitude of Hypotony and Time Course of Intraocular Pressure Recovery Following Anterior Chamber Cannulation in Nonhuman Primates.

Authors:  Jessica V Jasien; Carrie Huisingh; Christopher A Girkin; J Crawford Downs
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-06-01       Impact factor: 4.799

Review 6.  Intraocular Biopsy and ImmunoMolecular Pathology for "Unmasking" Intraocular Inflammatory Diseases.

Authors:  Rodolfo Mastropasqua; Emma Di Carlo; Carlo Sorrentino; Cesare Mariotti; Lyndon da Cruz
Journal:  J Clin Med       Date:  2019-10-19       Impact factor: 4.241

7.  Anterior vitrectomy, phacoemulsification cataract extraction and irido-zonulo-hyaloid-vitrectomy in protracted acute angle closure crisis.

Authors:  Xiaowei Yu; Zhenni Zhao; Dandan Zhang; Xue Yang; Nannan Sun; Yixiu Lin; Jiamin Zhang; Zhigang Fan
Journal:  Int Ophthalmol       Date:  2021-04-27       Impact factor: 2.031

8.  Breakdown of the blood-ocular barrier as a strategy for the systemic use of nanosystems.

Authors:  Marcelo L Occhiutto; Fatima R Freitas; Raul C Maranhao; Vital P Costa
Journal:  Pharmaceutics       Date:  2012-05-14       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.